Agent used in spinal surgery linked to higher complications rate, greater inpatient charges

A new study indicates that bone-morphogenetic protein (BMP; a biological agent used to promote bone creation) is used in 25 percent of spinal fusion procedures and is associated with a higher rate of complications than in fusions that did not use BMP, and greater hospital charges for all categories of spinal fusions, according to a report in the July 1 issue of JAMA.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news165598618.html">Agent used in spinal surgery linked to higher complications rate, greater inpatient charges</a></p> <p>A new study indicates that bone-morphogenetic protein (BMP; a biological agent used to promote bone creation) is used in 25 percent of spinal fusion procedures and is associated with a higher rate of complications than in fusions that did not use BMP, and greater hospital charges for all categories of spinal fusions, according to a report in the July 1 issue of <i>JAMA</i>. </p>